Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Human Vaccines & Immunotherapeutics|July 8, 2026
Elranatamab: A novel B-cell maturation T-cell engagerShahrier Hossain, Giada BianchiJACC. Cardiooncology|March 16, 2026
Cardiovascular Adverse Events Associated With Bispecific T-Cell Engager TherapyOsnat Itzhaki Ben Zadok, Shai Shimony, Shannon Miller, et al.Blood|July 25, 2025
Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain AmyloidosisPedro Vianna, Rajshekhar Chakraborty, Shahrier Hossain, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 11, 2021
A retrospective observational study of a low fixed-dose rasburicase protocol for the treatment of tumor lysis syndrome in adultsShahrier Hossain, Martha Naber, Matthew J YacobucciExpert Opinion on Drug Safety|October 31, 2023
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myelomaShonali Midha, Monique A Hartley-Brown, Clifton C Mo, et al.Hematology/Oncology Clinics of North America|October 25, 2020
Systemic Amyloidosis Due to Clonal Plasma Cell DiseasesGiada Bianchi, Shaji KumarHematology/Oncology Clinics of North America|April 3, 2012
Does my patient with a serum monoclonal spike have multiple myeloma?Giada Bianchi, Irene M GhobrialCurrent Gastroenterology Reports|January 27, 2018
Heavy Chain Disease of the Small BowelGiada Bianchi, Aliyah R SohaniLeukemia & Lymphoma|August 18, 2012
Molecular mechanisms of effectiveness of novel therapies in multiple myelomaGiada Bianchi, Irene M GhobrialCancer Journal (Sudbury, Mass.)|January 30, 2019
Contribution of Inhibition of Protein Catabolism in MyelomaGiada Bianchi, Kenneth C AndersonPageof 10